Carlsmed’s Education and Outcomes Driving Volume Growth
The company grew more than 50% in the first quarter of 2026 as its personalized lumbar and cervical systems gain adoption. May 15, 2026
Treace Looks to Weather Storm in 2026 as Mix Shifts
The company's sales declined more than 10% as its mix shifts away from Lapiplasty toward lower-cost MIS bunion systems. May 14, 2026
Smith+Nephew’s Segment Performance Shows Promising Trends
Our chart of the month looks at Smith+Nephew's historical segment performance, with a focus on sports medicine and hip replacement. May 14, 2026
Globus’ Strong 1Q Brings New Approach for Technology
The company's base business grew 13.2% in the first quarter of 2026, driven by continued strength in spine and resurgent enabling technology. May 13, 2026
Bioventus Q1 Exceeds Expectations on Rebate Lift
The company grew in the high single digits in the first quarter of 2026 due to broad strength across its businesses and an HA rebate lift. May 13, 2026
Enovis’ New Products Grow Recon Footprint
The company grew nearly 11% on a reported basis in the first quarter of 2026, driven by shoulder and hip growth. May 12, 2026
ATEC Adjusts 2026 Guidance on EOS Shortfall
The company grew in the low teens during the first quarter of 2026 as it drove strong surgical sales results, but saw EOS unit sales slow. May 12, 2026
Takeaways from THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT
Highlights from the brand new 2026 edition include the health of end markets, dynamics at play in the trauma segment, and the tantalizing promise of orthobiologics. May 11, 2026
Orthopedic Companies Report Results from First Quarter 2026
Stay up to date on the orthopedic market's 1Q performance in 2026 as we update this post with company sales data and industry developments. May 11, 2026
Smith+Nephew Delivers Strong Quarter Despite Knee Softness
The company grew in the high single digits in the first quarter of 2026 on the strength of hips and sports medicine. May 08, 2026
